WASHINGTON, DC--(Marketwire - June 23, 2008) - Syndication Inc. (OTCBB: SYDI) reports that on Thursday the 19th of June 2008, its subsidiary, Spinal Decompression and Disc Centers of America, signed with Chase Health Advance for the purpose of providing our customers with financial packages to cover uninsured medical costs related to various elective medical procedures including spinal decompression. The financing is provided by a revolving line of credit from Chase Bank USA, N.A., (Chase Revolving Account). The arrangement allows the Company to offer customers 0% interest finance options in packages ranging from $300.00 to $12,000.00, with 3 to 24-month payment plans. The service allows us to approve qualified patients within 3 to 20 minutes and can be concluded within the normal time needed for the Doctor to complete his initial patient consultation. Under the arrangement, Chase pays the company within 24 hours and bills the patient on the terms outlined by their finance package. "This program is a great addition to the service menu we can offer to our patients. It opens many payment options to the patient as well as

1-800-511-back; www.spinaldecompression-md.com/

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.